Dr. Muhammad Salman Azhar, PhD, is a clinician-scientist specializing in hepatobiliary and pancreatic diseases, with a primary research focus on cholangiocarcinoma. He completed his doctoral training at Xiangya School of Medicine, Central South University, Changsha, China, and is affiliated with Xiangya Second Hospital. He is a registered medical practitioner with the Pakistan Medical & Dental Council. Dr. Azhar has extensive clinical and research experience in hepatobiliary and pancreatic surgery and translational oncology. He has been involved in over 1,300 surgical procedures, including open, laparoscopic, and robotic approaches. His research focuses on the molecular mechanisms driving cholangiocarcinoma progression, particularly transcriptional regulation, tumor biology, and therapeutic interventions such as photodynamic therapy. Dr. Azhar has received several academic distinctions, including the Chinese Government Scholarship and national-level awards for overseas researchers. His long-term research goal is to integrate molecular biology, advanced imaging, and minimally invasive therapeutic approaches to improve diagnosis, precision treatment, and clinical outcomes in hepatobiliary malignancies, particularly cholangiocarcinoma.